PHOTO
ABU DHABI, United Arab Emirates: Rafed, Abu Dhabi’s group purchasing organization (GPO) for healthcare supplies and equipment, has celebrated a new operational milestone after successfully overseeing the storage and supply of millions of COVID-19 vaccines doses via its dedicated Rafed Distribution Center in the UAE capital.
The dedicated pharmaceutical facility, which measures 19,000 square meters and incorporates eight state-of-the-art cold chambers with the capacity to store up to 120 million vaccine vials, caters to all temperature bands ranging from 2-8ºC for PPE and medical equipment, to -80ºC deep freezer capabilities for vaccine storage.
Rashed Saif Al Qubaisi, Chief Executive Officer of Rafed, said: “What the Rafed team has been able to achieve over the past seven months is incredible and our facilities continue to play a critical role in enabling the UAE’s immunization initiatives. We are still a relatively young company and the ability to process over three million vaccine doses each month is proof that Rafed is providing a key link in the nation’s logistics chain and enabling centralized procurement services across the Emirates.”
In addition to essential cold storage facilities for COVID-19 vaccines, the Rafed Distribution Center also houses cutting-edge radio frequency scanning for dispatch and inventory control systems, as well as advanced building monitoring.
“This is a critical milestone for Rafed and the entire healthcare supply chain,” added Al Qubaisi. “While our priority has been the rapid supply of COVID-19 vaccines, our aim is to build on the facility’s success in coming months and expand our ability to reduce operational costs for healthcare providers while ensuring effective and timely delivery of essential medical supplies across the region.”
In addition to COVID-19 vaccine doses, the Rafed Distribution Center houses syringes and needles used in the delivery of the vaccine and personal protective equipment (PPE).
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
